Yingmei Feng

9.8k total citations · 1 hit paper
99 papers, 3.3k citations indexed

About

Yingmei Feng is a scholar working on Molecular Biology, Infectious Diseases and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yingmei Feng has authored 99 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 24 papers in Infectious Diseases and 23 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yingmei Feng's work include COVID-19 Clinical Research Studies (19 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Lipid metabolism and disorders (11 papers). Yingmei Feng is often cited by papers focused on COVID-19 Clinical Research Studies (19 papers), SARS-CoV-2 and COVID-19 Research (17 papers) and Lipid metabolism and disorders (11 papers). Yingmei Feng collaborates with scholars based in China, Belgium and Netherlands. Yingmei Feng's co-authors include Ronghua Jin, Bart De Geest, Eline Van Craeyveld, Décio L. Eizirik, Thomas Mandrup‐Poulsen, Morten Tonnesen, Françoise Van Eylen, Alessandra K. Cardozo, Fernanda Ortis and Joachim Størling and has published in prestigious journals such as Circulation, Nature Communications and Blood.

In The Last Decade

Yingmei Feng

97 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development

2021 330 citations Miaomiao Zhao, Fangyuan Yang et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yingmei Feng China	26	1.3k	834	661	452	439	99	3.3k
Gang Xu China	24	1.5k 1.2×	1.3k 1.5×	544 0.8×	945 2.1×	447 1.0×	72	3.7k
Qing Chang China	30	857 0.7×	1.3k 1.6×	321 0.5×	418 0.9×	233 0.5×	128	3.4k
Bruce D. Uhal United States	40	619 0.5×	1.4k 1.7×	555 0.8×	441 1.0×	442 1.0×	120	5.5k
Keiji Kuba Japan	29	2.3k 1.8×	1.3k 1.5×	676 1.0×	487 1.1×	408 0.9×	59	5.2k
Eldad A. Hod United States	40	594 0.5×	1.7k 2.0×	222 0.3×	327 0.7×	548 1.2×	127	5.3k
Nicolas Vuilleumier Switzerland	35	651 0.5×	649 0.8×	738 1.1×	1.1k 2.4×	608 1.4×	172	3.8k
David V. Milford United Kingdom	33	462 0.4×	2.4k 2.9×	708 1.1×	562 1.2×	320 0.7×	102	5.8k
Takaaki Nakamura Japan	26	617 0.5×	940 1.1×	618 0.9×	178 0.4×	451 1.0×	112	2.7k
Mohamed Abu‐Farha Kuwait	33	555 0.4×	1.3k 1.6×	237 0.4×	207 0.5×	567 1.3×	129	3.4k
Renu Sarao Canada	17	1.8k 1.4×	2.0k 2.4×	349 0.5×	726 1.6×	315 0.7×	20	5.8k

Countries citing papers authored by Yingmei Feng

Since Specialization

Citations

This map shows the geographic impact of Yingmei Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingmei Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingmei Feng more than expected).

Fields of papers citing papers by Yingmei Feng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingmei Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingmei Feng. The network helps show where Yingmei Feng may publish in the future.

Co-authorship network of co-authors of Yingmei Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Yingmei Feng. A scholar is included among the top collaborators of Yingmei Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingmei Feng. Yingmei Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jiaying, Yuan Gao, Wei Wang, et al.. (2025). Severe metabolic accumulation of VV116 in kidney transplant patients with impaired renal function: a case series report. Frontiers in Immunology. 15. 1501813–1501813. 1 indexed citations

Liang, Fanrong, Jie Li, Yingmei Feng, et al.. (2025). Advances and prospects in Alzheimer's disease diagnosis and treatment using MOFs and COFs: Mechanism and AI-assisted strategies. Reactive and Functional Polymers. 219. 106601–106601.

Zhang, Yuejie, Yalan Deng, Li Su, et al.. (2024). ANGPTL3 accelerates atherosclerotic progression via direct regulation of M1 macrophage activation in plaque. Journal of Advanced Research. 70. 125–138. 8 indexed citations

Zhao, Miaomiao, Xiaoya Li, Jianmin Jin, et al.. (2024). Hyperglycemia induced cathepsin L maturation linked to diabetic comorbidities and COVID-19 mortality. eLife. 13. 1 indexed citations

Deng, Yalan, et al.. (2024). Targeting mitochondrial homeostasis in the treatment of non-alcoholic fatty liver disease: a review. Frontiers in Pharmacology. 15. 1463187–1463187. 5 indexed citations

Wang, Lifei, Fang Xie, Yanjun Wang, et al.. (2023). PNPLA3-I148M Variant Promotes the Progression of Liver Fibrosis by Inducing Mitochondrial Dysfunction. International Journal of Molecular Sciences. 24(11). 9681–9681. 16 indexed citations

Ma, Xiaojuan, Sin Man Lam, Yuejie Zhang, et al.. (2023). Exendin-4 attenuates atherosclerosis progression via controlling hematopoietic stem/progenitor cell proliferation. Journal of Molecular Cell Biology. 15(2). 1 indexed citations

Wang, Lu, Xing Hu, Xiaoni Liu, et al.. (2022). m7G regulator-mediated methylation modification patterns define immune cell infiltration and patient survival. Frontiers in Immunology. 13. 1022720–1022720. 2 indexed citations

Wang, Chunqing, Xing Zhang, Liping Luo, et al.. (2022). Adipocyte-derived PGE2 is required for intermittent fasting–induced Treg proliferation and improvement of insulin sensitivity. JCI Insight. 7(5). 19 indexed citations

10.

Lam, Sin Man, Yuan Dong, Xiaojuan Ma, et al.. (2022). The purine metabolite inosine monophosphate accelerates myelopoiesis and acute pancreatitis progression. Communications Biology. 5(1). 1088–1088. 3 indexed citations

11.

Cao, Yu, Peiyao Li, Lu Li, et al.. (2022). Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant. Emerging Microbes & Infections. 11(1). 749–752. 13 indexed citations

12.

Zhang, Yuejie, et al.. (2021). Diabetic Bone Marrow Cell Injection Accelerated Acute Pancreatitis Progression. Journal of Immunology Research. 2021. 1–14. 3 indexed citations

13.

Wang, Xiaoli, Xianghua Guo, Qianqian Xin, et al.. (2020). Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients. Clinical Infectious Diseases. 71(10). 2688–2694. 193 indexed citations

14.

Leng, Ling, Ruiyuan Cao, Jie Ma, et al.. (2020). Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples. Signal Transduction and Targeted Therapy. 5(1). 240–240. 112 indexed citations

15.

Shi, Hongbo, Wenjing Wang, Jiming Yin, et al.. (2020). The inhibition of IL-2/IL-2R gives rise to CD8+ T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia. Cell Death and Disease. 11(6). 429–429. 63 indexed citations

16.

Tian, Wenmin, Nan Zhang, Ronghua Jin, et al.. (2020). Immune suppression in the early stage of COVID-19 disease. Nature Communications. 11(1). 5859–5859. 164 indexed citations

17.

Wang, Wenjing, Bin Su, Lijun Pang, et al.. (2020). High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients. Cellular and Molecular Immunology. 17(6). 650–652. 99 indexed citations

18.

Yu, Cai‐Guo, Wen‐Yi Yang, Nelly D. Saenen, et al.. (2019). Neurocognitive function in relation to blood lead among young men prior to chronic occupational exposure. Scandinavian Journal of Work Environment & Health. 45(3). 298–307. 7 indexed citations

19.

Jacobs, Frank, Eline Van Craeyveld, Yingmei Feng, & Bart De Geest. (2009). The diameter of liver sinusoidal fenestrae is not a major determinant of lipoprotein levels and atherosclerosis in cholesterol-fed rabbits. Cardiovascular Pathology. 20(1). 44–50. 3 indexed citations

20.

Linthout, Sophie Van, Frank Spillmann, Anna Foryst‐Ludwig, et al.. (2007). Increased high density lipoprotein cholesterol induced by human apolipoprotein A-1 gene transfer increases adiponectin expression in abdominal adipose tissue. Circulation. 116(16). 286–286. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact